Daxas in COPD Therapy

Trial Profile

Daxas in COPD Therapy

Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2016

At a glance

  • Drugs Roflumilast (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Acronyms DINO
  • Sponsors Takeda; Takeda Pharmaceuticals International GmbH
  • Most Recent Events

    • 04 May 2012 Takeda Global Research and Development Center added as company and lead trial centre as reported by ClinicalTrials.gov.
    • 30 Jan 2011 Status changed from not yet recruiting to recruiting according to a ClinicalTrials.gov record.
    • 28 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top